GANX · Gain Therapeutics, Inc.
$1.81
-0.10 (-4.99%)
At close · Aug 26
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our projected cash outflows for the upcoming periods raise substantial doubt about our ability to continue as a going concern for at least 12 months from the issuance of the financial statements included elsewhere in this Quarterly Report.”View the 10-Q filed Aug 11, 2026
Market Cap
$83.14M
Shares
43.64M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
Key facts
CIK
1819411
CUSIP
36269B105
13F (30d)
45 filings
45 filers
Visit website
Investor relations